Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004446 · ClinicalTrials.gov registry record · NA
Study of Fluoxetine in Patients With Depersonalization Disorder
A NA study, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT00004446 is a NA study that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 80 participants.
The verdict
NCT00004446, a NA study, has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to: 1\) Determine the effects of fluoxetine in the treatment of depersonalization disorder, 2) Assess the durability of treatment response in these patients, 3) Assess the improvement in psychiatric disability in these patients, and 4) Assess the effects of comorbid Axis I disorders (depression, social phobia, panic/anxiety, obsessive-compulsive disorder) and Axis II personality disorders on treatment outcome in these patients.
Interventions
- DRUG fluoxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 1998-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004446
The ClinicalTrials.gov registry entry for NCT00004446 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fluoxetine is the first listed.
NCT00004446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004446 about?
NCT00004446 is a clinical study titled "Study of Fluoxetine in Patients With Depersonalization Disorder". The purpose of this study is to: 1\) Determine the effects of fluoxetine in the treatment of depersonalization disorder, 2) Assess the durability of treatment response in these patients, 3) Assess the improvement in psychiatric disability in these patients, and 4) Assess the effects of comorbid Axi...
What is the current status of trial NCT00004446?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 1998-04.
What interventions are being tested in trial NCT00004446?
The interventions under investigation include: fluoxetine (DRUG).
Who is sponsoring clinical trial NCT00004446?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.